NCT00612560View on ClinicalTrials.gov

Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

April 30, 2014

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole

1 mg per day

DIETARY_SUPPLEMENT

flaxseed

25 g per day ground

DRUG

Placebo

Placebo pill 1 per day

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

AstraZeneca

INDUSTRY

lead

Roswell Park Cancer Institute

OTHER